Article Details

Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with ...

Retrieved on: 2024-05-20 20:41:41

Tags for this article:

Click the tags to see associated articles and topics

Second Phase 3 clinical trial again shows dupilumab lessens disease in COPD patients with .... View article details on hiswai:

Excerpt

This monoclonal antibody is the first biologic shown to improve clinical outcomes in COPD. The data supporting the use of dupilumab in COPD will be ...

Article found on: www.eurekalert.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo